LBA79 Lenvatinib plus pembrolizumab and chemotherapy vs pembrolizumab and chemotherapy in untreated metastatic esophageal squamous cell carcinoma: The randomized phase III LEAP-014 study

作者：J-M. Sun, S-B. Kim, Takashi Ogata, Min Hee Hong, Muammer Bilici, Shun Yamamoto, D. Kotani, Ezequiel Slutsky, Chin‐Yo Lin, Sang Cheul Oh, C-H. Hsu, Tao Deng, Ying Zhang, Peter C. Enzinger, Hanneke W. M. van Laarhoven, A. Adenis, Wei He, Kanu Sharan, Manan Shah, Li Shen · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.09.094 · 被引用次数：4 · 研究领域：Esophageal Cancer Research and Treatment、Cancer Immunotherapy and Biomarkers、Colorectal and Anal Carcinomas